Category

Biotechs

Biotechnology

Top 7 Pharmaceutical Stocks to Buy Right Now

By , Money Morning - • Print | Email

Biotech companies are racing to develop a coronavirus vaccine. And investors are racing to profit from it. In fact, CBSNews reported on May 28 that the rush created a $200 billion stock market bubble.

Many flocked to Gilead Sciences, Inc. (NASDAQ: GLD) after the company announced its "Remdesivir" treatment for COVID-19.

But you don't have to follow the crowd. And you don't have to cast a mindless net over just any biotech stocks you find in the COVID-19 crisis. We're going to share with you some of the best pharma stocks to buy right now. These could be some of the most promising pharmaceuticals for coronavirus vaccine and treatment hopes.

Read more here...

How to Identify the Real Winners of the COVID-19 Vaccine Race

By , Defense + Tech Specialist, Money Morning • @Robinson_STI - • Print | Email

Living in California where we have had the fourth-highest amount of cases of any state, I've seen firsthand the dramatic impact of the coronavirus on our daily lives.

Storefronts have closed, and major San Francisco employers, like Facebook, have given employees the option to work from home indefinitely.

Of course, some cities have started to open back up, but it has not been a great start. There's still plenty of uncertainty out there. Cases have risen in Houston, and Virginia just reported its highest per-day increase of COVID-19 cases.

This is why the need for a vaccine is so important and why the biopharma industry has received such close attention by the public and investors over the last few months… Full Story

This is why the need for a vaccine is so important and why the biopharma industry has received such close attention by the public and investors over the last few months... Full Story

Stocks

This Deal Could Put You Up Much More Than 149%

By , Executive Editor, Money Morning - • Print | Email

It was the very first stock that I recommended on the very first day we published Private Briefing nearly eight years ago…

I've re-recommended the shares to my readers several times, and when something happened that I felt everyone should know about, we made sure to get the news out in Money Morning, too.

When I first wrote about it in 2011, shares were trading at $8.60. As of Wednesday morning, the stock was sitting near all-time highs at $171 – monumental gains of nearly 1,900%.

But I'm writing today because it's been a big winner for you, too – more than 149%.

And I don't think it's done, not by a long shot…

Let me tell you about the company - and all about this latest development...

Biotechnology

Biotech IPOs Are Getting the Headlines - Here's Where You'll Find the Profits

By , Guest Writer, Money Morning - • Print | Email

For many investors in 2019, the name of the game is speculation.

Of course, it has also been a huge year for initial public offerings. As always, IPOs and speculation often go hand in hand.

As we look ahead to the second half of 2019, IPOs will be one of the biggest focuses, and we expect the biotech IPOs to take center stage.

Read more...

Marijuana Industry

Trump's New Drug Price Rule Is a Boon to Cannabis Stocks

By , Money Morning - • Print | Email

The U.S. Department of Health & Human Services (HHS) just finalized its rules requiring pharmaceutical companies to list drug prices in their TV ads this summer.

It's a huge catalyst for cannabis stocks going toe to toe with Big Pharma.

One cannabis stock in particular is already expecting more than 200% sales growth this year, but its gains from this new executive order could be unheard of.

Read more here...

stocks

The 3 Best Biotech Stocks to Buy as the Sector's Rally Continues

By , Guest Writer, Money Morning - • Print | Email

Right now, the biotech sector and Nasdaq are moving in lockstep.

Thus far in 2019, the iShares Nasdaq Biotechnology ETF (IBB) has gained 18.76%. By comparison, the technology-heavy Nasdaq index is up just over 19% this year.

Back in 1998, the same pattern was forming before biotech stocks truly broke out.

So despite the gains in the biotechnology sector in 2019, there are more gains to be had...

stocks

2 More Biotech Stocks Are Flashing Buy Signals Today

By , Guest Writer, Money Morning - • Print | Email

At the end of 2018, the Federal Reserve told the market the water was warm, come in for a swim.

The market was happy to oblige. In fact, the S&P 500 has rebounded almost 11% to start 2019, nearly erasing all of the losses from December.

It's as if the sell-off never happened.

Right now, the market is an absolute dream for stock pickers. And biotech stocks in particular are looking incredibly lucrative...